Literature DB >> 11677935

1114 total gastrectomies in the surgical treatment of primary gastric adenocarcinoma--a 30-year single institution experience.

J Jähne1, P Piso, H J Meyer.   

Abstract

BACKGROUND/AIMS: Surgical therapy still represents the standard treatment for gastric carcinoma. Due to epidemiology and tumor stage, total gastrectomy is the most often required extent of gastric resection to obtain a potentially curative status. After a 30-year period we overviewed 1114 total gastrectomies, to our knowledge one of the biggest single-institution series in the Western Hemisphere.
METHODOLOGY: Among 1991 cases with gastric carcinoma, treated between May 1968 and February 1998, 1114 patients underwent total gastrectomy. This prospectively documented series was retrospectively analyzed with special focus on various time periods.
RESULTS: A constant increase of proximal gastric carcinomas was noted. R0-resections were feasible in 84.6% of total gastrectomies. Morbidity and mortality decreased to 22.2% and 5.5%, respectively, in the last decade. Overall 5-years survival rate was 32.4%. Survival was strongly influenced by tumor stage and R-classification. Overall and prognosis after R0-resection showed a significant time-dependent improvement.
CONCLUSIONS: Total gastrectomy requires intensive surgical skills and can be performed with acceptable morbidity and low mortality. Survival after total gastrectomy can be improved with increasing experience, and the aim of total gastrectomy for gastric carcinoma should always focus on a R0-resection.

Entities:  

Mesh:

Year:  2001        PMID: 11677935

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy.

Authors:  Dao-Jun Gong; Chao-Feng Miao; Qi Bao; Ming Jiang; Li-Fang Zhang; Xiao-Tao Tong; Li Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

2.  Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer.

Authors:  Saleh M Abbas; M W Booth
Journal:  Langenbecks Arch Surg       Date:  2005-01-15       Impact factor: 3.445

3.  Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.

Authors:  Steven C Cunningham; Farin Kamangar; Min P Kim; Sommer Hammoud; Raqeeb Haque; Anirban Maitra; Elizabeth Montgomery; Richard E Heitmiller; Michael A Choti; Keith D Lillemoe; John L Cameron; Charles J Yeo; Richard D Schulick
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

4.  Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.

Authors:  Valerie K Reed; Sunil Krishnan; Paul F Mansfield; Priya R Bhosale; Michelle Kim; Prajnan Das; Nora A Janjan; Marc E Delclos; Andrew M Lowy; Barry W Feig; Peter W T Pisters; Jaffer A Ajani; Christopher H Crane
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

5.  The overlap method is a safe and feasible for esophagojejunostomy after laparoscopic-assisted total gastrectomy.

Authors:  Mamoru Morimoto; Hidehiko Kitagami; Tetsushi Hayakawa; Moritsugu Tanaka; Yoichi Matsuo; Hiromitsu Takeyama
Journal:  World J Surg Oncol       Date:  2014-12-20       Impact factor: 2.754

6.  Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years.

Authors:  Fausto Rosa; Sergio Alfieri; Antonio Pio Tortorelli; Claudio Fiorillo; Guido Costamagna; Giovanni Battista Doglietto
Journal:  World J Surg Oncol       Date:  2014-07-16       Impact factor: 2.754

7.  Hiatal Hernia as a Total Gastrectomy Complication.

Authors:  Bruna do Nascimento Santos; Marcos Belotto de Oliveira; Renata D'Alpino Peixoto
Journal:  Case Rep Oncol       Date:  2016-02-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.